πŸ‡ΊπŸ‡Έ FDA
Patent

US 7960384

Dipeptidyl peptidase inhibitors

granted A61PA61P35/00

Quick answer

US patent 7960384 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61P, A61P35/00